glp-1 eligibility What to say when requesting options: guide to getting your prescription qualifications for glp-1 meds GLP-1
Description
Her lifelong struggles with weight have led her to recognize the value of having treatment options today
The FDA approved CV risk reduction as additional indication for Wegovy and obstructive sleep apnoea for Zepbound
Weight Loss: GLP-1 agonists will slow down the digestion of food and give a feeling of satiety
%20(1).png)
For most symptomatic patients the evidence-based answer is yes, because symptoms tend to recur and complications carry significant morbidity
